Skip to main content
SpringerLink
Log in

Underdetection of clinical benign prostatic hyperplasia in a general medical practice

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

OBJECTIVE: To measure detection of clinical benign prostatic hyperplasia (BPH) in a general medicine practice.

DESIGN: Self-administered questionnaire and retrospective ambulatory medical record review.

SETTING: Hospital-based general medicine practice.

PATIENTS: Two hundred and four men aged 50 years and older.

MEASUREMENTS AND M AIN RESULTS: Clinical information was obtained from a self-administered questionnaire containing the American Urological Association symptom index and the BPH Impact Index bother scale, and from retrospective review of ambulatory medical records for the previous 24 months. Thirty percent of patients had moderate to severe urinary tract symptoms, and 67% of these individuals were bothered by the symptoms. Only 52% with moderate to severe symptoms recalled any discussion with their primary care physician about their symptoms. There was medical record documentation of a review of urinary tract symptoms in only 18% and a prostate examination in only 64%. Patients with more symptoms and bother tended to recall a discussion of urinary tract symptoms with their physician. However, moderate to severe symptoms and bother were not associated with increased documentation of a history of urinary tract symptoms or prostate examination.

CONCLUSIONS: Clinical BPH was underdetected in a general medicine practice. Because many men do not complain to their physicians about urinary tract symptoms and reduced quality of life, perhaps primary care physicians should pay more attention to recognizing this common condition of older men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 1990;17:495–507.

    PubMed  CAS  Google Scholar 

  2. Barry MJ, Boyle P, Garraway M, et al. Epidemiology and natural history of BPH. In: Cockett ATK, Khoury S, Aso Y, et al., eds. The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Jersey, Channel Islands: Scientific Communication International Ltd; 1993.

    Google Scholar 

  3. Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150:85–9.

    PubMed  CAS  Google Scholar 

  4. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology. 1993;42:36–41.

    Article  PubMed  CAS  Google Scholar 

  5. Diokno AC, Brown MB, Goldstein N, Herzog AR. Epidemiology of bladder emptying symptoms in elderly men. J Urol. 1992;148:1817–21.

    PubMed  CAS  Google Scholar 

  6. Meyhoff HH, Hald T. Are doctors able to assess prostatic size? Scand J Nephrol. 1978;12:219–21.

    CAS  Google Scholar 

  7. Girman CJ, Panser LA, Chute CG, et al. Natural history of prostatism: urinary flow rates in a community-based study. J Urol. 1993;150:887–92.

    PubMed  CAS  Google Scholar 

  8. Abrams P. In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology. 1994;44:153–5.

    Article  PubMed  CAS  Google Scholar 

  9. Watanabe H, Ohe H, Inaba T, Itakura Y, Saitoh M, Nakao M. A mobile mass screening unit for prostatic disease. Prostate. 1984;5:559–65.

    Article  PubMed  CAS  Google Scholar 

  10. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474–9.

    PubMed  CAS  Google Scholar 

  11. Lytton B, Emery JM, Harvard BM. The incidence of benign prostatic obstruction. J Urol. 1968;99:639–45.

    PubMed  CAS  Google Scholar 

  12. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate. 1989;2(suppl):33–50.

    Article  CAS  Google Scholar 

  13. Garraway WM, Collins GN, Lee RJ. High prevalence of benign pro-static hypertrophy in the community. Lancet. 1991;338:469–71.

    Article  PubMed  CAS  Google Scholar 

  14. Glynn RJ, Campion EW, Bouchard GR, Silbert JE. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol. 1985;121:78–90.

    PubMed  CAS  Google Scholar 

  15. Arrighi HM, Guess HA, Metter EJ, Fozard JL. Symptoms and signs of prostatism as risk factors for prostatectomy. Prostate. 1990;16:253–61.

    Article  PubMed  CAS  Google Scholar 

  16. Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17:241–6.

    Article  PubMed  CAS  Google Scholar 

  17. Barry MJ, Mulley AG, Fowler FJ, Wennberg JW. Watchful waiting vs immediate transurethral resection for symptomatic prostatism—the importance of patients’ preferences. JAMA. 1988;259:3010–17.

    Article  PubMed  CAS  Google Scholar 

  18. Barry MJ, Fowler FJ. The methodology for evaluating the subjective outcomes of treatment for benign prostatic hyperplasia. Adv Urol. 1993;6:83–99.

    Google Scholar 

  19. Fowler FJ, Barry MJ. Quality of life assessment for evaluating benign prostatic hyperplasia treatments. Eur Urol. 1993;24(suppl):24–7.

    PubMed  Google Scholar 

  20. Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care. 1995;33:AS145–55.

    Article  PubMed  CAS  Google Scholar 

  21. McConnell JD, Barry MJ, Bruskewitz RC, et al. Benign Prostatic Hyperplasia: Diagnosis and Treatment: Clinical Practice Guideline. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services: February 1994. AHCPR publication 94-0582; No. 8.

    Google Scholar 

  22. Tsang KK, Garraway WM. Impact of benign prostatic hyperplasia on general well-being of men. Prostate. 1993;23:1–7.

    Article  PubMed  CAS  Google Scholar 

  23. Hunter DWJ, McKee M, Black NA, Sanderson CFB. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology. 1995;45:962–71.

    Article  PubMed  CAS  Google Scholar 

  24. Garraway WM, Russell EBAW, Lee RJ, Collins GN. Impact of previously unrecognized benign prostatic hyperplasia on the lives of middle-aged and elderly men. Br J Gen Pract. 1993;43:318–21.

    PubMed  CAS  Google Scholar 

  25. Jacobsen SJ, Girman CJ, Guess HA, et al. Natural history of prostatism: factors associated with discordance between frequency and bother of urinary symptoms. Urology. 1993;42:663–71.

    Article  PubMed  CAS  Google Scholar 

  26. Jacobsen SJ, Guess HA, Panser L, et al. A population-based study of health care-seeking behavior for treatment of urinary symptoms. Arch Fam Med. 1993;2:729–35.

    Article  PubMed  CAS  Google Scholar 

  27. Beier-Holgers R, Bruun J. Voiding pattern of men 60–70 years old: population study in an urban population. J Urol. 1990;143:531–2.

    Google Scholar 

  28. Roberts RO, Chute CG, Rhodes T, et al. Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior. Urology. 1994;43:621–8.

    Article  PubMed  CAS  Google Scholar 

  29. Jacobsen SJ, Girman CJ, Guess HA, et al. Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men. Urology. 1995;45:64–9.

    Article  PubMed  CAS  Google Scholar 

  30. Simpson RJ, Lee RJ, Garraway WM, King D, Mclntosh I. Consultation patterns in a community survey of men with benign prostatic hyperplasia. Br J Gen Pract. 1994;44:499–502.

    PubMed  CAS  Google Scholar 

  31. Lepor H. Medical therapy for benign prostatic hyperplasia. Urology. 1993;42:483–501.

    Article  PubMed  CAS  Google Scholar 

  32. Monda JM, Oesterling JE. Medical treatment of benign prostatic hyperplasia: 5-alpha-reductase inhibitors and alpha-adrenergic antagonists. Mayo Clin Proc. 1993;68:670–9.

    PubMed  CAS  Google Scholar 

  33. Carlton GE, Altwein JE, Fortuno RF, et al. Benign prostatic hyperplasia professional and public education. In: Cockett ATK, Khoury S, Aso Y, et al., eds. The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Jersey, Channel Islands: Scientific Communication International Ltd; 1993.

    Google Scholar 

  34. Barry MJ. Medical outcomes research and benign prostatic hyperplasia. Prostate. 1990;3(suppl):61–74.

    Article  CAS  Google Scholar 

  35. Wennberg JE, Mulley AG, Hanley D, et al. An assessment of prostatectomy for benign urinary tract obstruction: geographic variations and the evaluation of medical care outcomes. JAMA. 1988;259:3027–30.

    Article  PubMed  CAS  Google Scholar 

  36. Barry MJ, Fowler FJ, O’Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549–57.

    PubMed  CAS  Google Scholar 

  37. Abrams P. New words for old: lower urinary tract symptoms for “prostatism.” BMJ. 1994;308:929–30.

    PubMed  CAS  Google Scholar 

  38. O’Leary MP, Barry MJ, Fowler FJ. Hard measures of subjective outcomes: validating symptom indexes in urology. J Urol. 1992;148:1546–8.

    PubMed  CAS  Google Scholar 

  39. Barry MJ, Fowler FJ, O’Leary MP, et al. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky, and Maine Medical assessment program symptom indexes. J Urol. 1992;148:1558–63.

    PubMed  CAS  Google Scholar 

  40. McKelvie GB, Collins GN, Hehir M, Rogers ACN. A study of benign prostatic hyperplasia—a challenge to British urology. Br J Urol. 1993;71:38–42.

    Article  PubMed  CAS  Google Scholar 

  41. Barry MJ. Guidelines: physicians in the lead. Health Manage Q. 1991;13:20–3.

    PubMed  CAS  Google Scholar 

  42. Eisenberg JM. The internist as gatekeeper: preparing the general internist for a new role. Ann Intern Med. 1985;102:537–43.

    PubMed  CAS  Google Scholar 

  43. Oesterling JE. Benign prostatic hyperplasia: medical and minimally invasive treatment options. N Engl J Med. 1995;332:99–109.

    Article  PubMed  CAS  Google Scholar 

  44. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hypertrophy. N Engl J Med. 1995;332:75–9.

    Article  PubMed  CAS  Google Scholar 

  45. Wennberg J, Gittelson A. Variations in medical care among small areas. Sci Am. 1982;246:120–34.

    Article  PubMed  CAS  Google Scholar 

  46. Mulley AG. Assessing patients’ utilities: can the end justify the means? Med Care. 1989;27:S269–81.

    Article  PubMed  Google Scholar 

  47. Wennberg JE. The road to guidelines. Health Manage Q. 1991;13:2–7.

    PubMed  CAS  Google Scholar 

  48. Mulley AG. Finding common ground. Health Manage Q. 1991;13:16–9.

    PubMed  Google Scholar 

  49. Fowler FJ, Wennberg JE, Timothy RP, Barry MJ, Mulley AG, Hanley D. Symptom status and quality of life following prostatectomy. JAMA. 1988;259:3018–22.

    Article  PubMed  Google Scholar 

  50. Flood AB, Black NA, McPherson K, Smith J, Williams G. Assessing symptom improvement after elective prostatectomy for benign pro-static hypertrophy. Arch Intern Med. 1992;152:1507–12.

    Article  PubMed  CAS  Google Scholar 

  51. Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995;33:771–82.

    Article  PubMed  CAS  Google Scholar 

  52. Jacobsen SJ, Girman CJ, Guess HA, et al. New diagnostic and treatment guidelines for benign prostatic hyperplasia: potential impact in the United States. Arch Intern Med. 1995;155:477–81.

    Article  PubMed  CAS  Google Scholar 

  53. Roberts RG. BPH: new guidelines based on symptoms and patient preference. Geriatrics. 1994;49:24–31.

    PubMed  CAS  Google Scholar 

  54. Chappie CR. Correlation of symptomatology, urodynamics, morphology and size of the prostate in benign prostatic hyperplasia. Curr Opin Urol. 1993;3:5–9.

    Article  Google Scholar 

  55. Barry MJ. Cockett ATK, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 1993;150:351–8.

    PubMed  CAS  Google Scholar 

  56. Jensen KME, Jorgensen JB, Mogensen P, Bille-Brahe NE. Some clinical aspects of uroflowmetry in elderly males: a population survey. Scand J Urol Nephrol. 1986;20:93–9.

    PubMed  CAS  Google Scholar 

  57. Goldman L. Enlightened individual choice vs the public health: rational prevention from whose perspective? J Gen Intern Med. 1995;10:147–50.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of General Internal Medicine, Evans Department of Medicine, Boston Medical Center, 720 Harrison Ave., Suite 1108, 02118, Boston, MA

    Mark A. Moskowitz MD

Authors
  1. Mary F. McNaughton Collins MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert H. Friedman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arlene Ash PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruth Hall MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mark A. Moskowitz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received from the Section of General Internal Medicine, Evans Memorial Department of Medicine, Boston Medical Center, Mass.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McNaughton Collins, M.F., Friedman, R.H., Ash, A. et al. Underdetection of clinical benign prostatic hyperplasia in a general medical practice. J Gen Intern Med 11, 513–518 (1996). https://doi.org/10.1007/BF02599597

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02599597

Key words

Search

Navigation